1. Exploring Dysregulated Signaling Pathways in Cancer
   Sabah Nisar et al, 2020, Current Pharmaceutical Design CrossRef
2. Recent Advances in Oral Cancer Research
   Deepika Mishra et al, 2021, Management of Oral Cancers CrossRef
3. Serum CRIPTO does not confer drug resistance against osimertinib but is an indicator of tumor burden in non-small cell lung cancer
   Vincent Chen et al, 2020, Lung Cancer CrossRef
4. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
   Hiroko Ishii et al, 2021, International Journal of Molecular Sciences CrossRef
5. A Novel Localization in Human Large Extracellular Vesicles for the EGF-CFC Founder Member CRIPTO and Its Biological and Therapeutic Implications
   Francesca Mantile et al, 2022, Cancers CrossRef
6. Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
   Hiroko Ishii et al, 2021, Cancers CrossRef
7. Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
   David W. Freeman et al, 2021, International Journal of Molecular Sciences CrossRef